Omada Health to Present Peer-Reviewed Research on GLP-1 Treatment at World Obesity and Weight Management Congress

Omada Health will present peer-reviewed research at the World Obesity and Weight Management Congress, focusing on the effectiveness of its digital care interventions for individuals on GLP-1 treatment. This study aims to provide clinically validated data supporting the company's chronic condition management programs. The announcement was made on October 20, 2026.